Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy

M.A. Tortorici*, T. Yuraszeck, D. Cornblath, V. Bril, H.P. Hartung, G. Sobue, R.A. Lewis, I.S.J. Merkies, J.P. Lawo, M. Praus, B.L. Durn, O. Mielke, X.W. Ma, P. Jauslin, M. Pfister, I.N. Schaik, PATH Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)839-850
Number of pages12
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume10
Issue number8
DOIs
Publication statusPublished - 1 Aug 2021

Keywords

  • SUBCUTANEOUS IMMUNOGLOBULIN

Cite this